Drug

Selpercatinib clinical trials

Also written LOXO-292, LY3527723 and Retevmo.

studies test it: 30
open now: 5
in phase 3: 3
first study started: 2016

Keep track of what changes. Save the selpercatinib studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Studies by the year they started

30 studies that test it; most in 2021 (6)

Studies that test selpercatinib, by start year
Year	Studies
2016	1
2017	2
2018	5
2019	4
2020	5
2021	6
2022	2
2023	2
2025	1
2026	2

By phase

A phase 1/2 study counts in both.

Early Phase 1: 1
Phase 1: 15
Phase 2: 11
Phase 3: 3
Phase 4: 2

What it is tested for

Each study’s main condition, where its own words name it.

Carcinoma, Non-Small-Cell Lung: 5
Thyroid Neoplasms: 3
Ependymoma: 1
Histiocytosis, Langerhans-Cell: 1
Gastrointestinal Neoplasms: 1
Renal Insufficiency: 1
Thyroid Cancer, Papillary: 1
Neoplasms: 1

Who runs them

Industry 20 · Other 10

Eli Lilly and Company (15) · Loxo Oncology, Inc. (5) · National Cancer Institute (NCI) (2) · SWOG Cancer Research Network (2) · M.D. Anderson Cancer Center (1) · Fondazione per la Medicina Personalizzata (1) · University of Oklahoma (1) · Fujian Medical University (1)

Often tested with

Tested in the same studies.

Palbociclib (3) · Vemurafenib (3) · Erdafitinib (2) · Larotrectinib (2) · Olaparib (2) · Erlotinib (2) · Trastuzumab (2) · Pertuzumab (2)

Studies

Open first, then newest update. How each study uses selpercatinib is read from its arms, and is right about nine times in ten.

Testing it · 30

See all 30 studies that test selpercatinib →

Given in every arm · 3 — selpercatinib is usual care beside what is tested

Codes

What other systems call selpercatinib · ClinicalTrials.gg INT001233

MeSH (NLM) C000656166selpercatinibConfirmed ClinicalTrials.gov, NLM
UNII (FDA) CEGM9YBNGDSELPERCATINIBConfirmed FDA, NLM, Wikidata
RxNorm 2370147One source FDA
Wikidata Q96405266selpercatinibConfirmed FDA, NLM, Wikidata
NCI Thesaurus C134987SelpercatinibOne source FDA
DrugBank DB15685One source Wikidata

System	Code	Name there	Checked by
MeSH (NLM)	C000656166	selpercatinib	Confirmed ClinicalTrials.gov, NLM
UNII (FDA)	CEGM9YBNGD	SELPERCATINIB	Confirmed FDA, NLM, Wikidata
RxNorm	2370147	—	One source FDA
Wikidata	Q96405266	selpercatinib	Confirmed FDA, NLM, Wikidata
NCI Thesaurus	C134987	Selpercatinib	One source FDA
DrugBank	DB15685	—	One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.